DOI:
10.1055/s-00000075
Seminars in Respiratory and Critical Care Medicine
LinksClose Window
References
Corren J, Weinstein S, Janka L, Zangrilli J, Garin M.
Phase 3 Study of Reslizumab in Patients With Poorly Controlled Asthma: Effects Across a Broad Range of Eosinophil Counts.
Chest 2016;
150 (04) 799-810
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.